🇺🇸 FDA
Patent

US 10100279

In vitro production of medial ganglionic eminence precursor cells

granted A61PA61P25/00

Quick answer

US patent 10100279 (In vitro production of medial ganglionic eminence precursor cells) held by The Regents of the University of California expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P25/00